SPXV:NYE-ProShares S&P 500® ex-Health Care ETF (USD)

ETF | Large Blend |

Last Closing

USD 60.74

Change

-0.07 (-0.11)%

Market Cap

USD 0.02B

Volume

628.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Under normal circumstances, the fund will invest at least 80% of its total assets in component securities of the index. The index and fund seek to provide exposure to the companies of the S&P 500® Index (the S&P 500®) with the exception of those companies included in the Health Care Sector.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Large Blend

Symbol Name Price(Change) Market Cap
VTI Vanguard Total Stock Market In..

+0.06 (+0.02%)

USD 439.91B
SPLG SPDR® Portfolio S&P 500 ETF

+0.02 (+0.03%)

USD 46.15B
SCHX Schwab U.S. Large-Cap ETF

+0.05 (+0.07%)

USD 45.97B
GSLC Goldman Sachs ActiveBeta® U.S..

+0.16 (+0.14%)

USD 12.90B
DYNF BlackRock US Equity Factor Rot..

+0.07 (+0.14%)

USD 12.01B
SPTM SPDR® Portfolio S&P 1500 Comp..

-0.02 (-0.03%)

USD 9.16B
SPLV Invesco S&P 500® Low Volatili..

-0.12 (-0.17%)

USD 7.54B
JQUA JPMorgan U.S. Quality Factor E..

+0.12 (+0.21%)

USD 5.08B
SCHK Schwab 1000 ETF

+0.08 (+0.15%)

USD 3.80B
SUSA iShares MSCI USA ESG Select

-0.05 (-0.04%)

USD 3.71B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.72% 85% B 81% B-
Dividend Return 1.03% 55% F 19% F
Total Return 21.75% 86% B+ 79% B-
Trailing 12 Months  
Capital Gain 35.83% 92% A 80% B-
Dividend Return 1.64% 60% D- 22% F
Total Return 37.47% 93% A 78% C+
Trailing 5 Years  
Capital Gain 96.17% 83% B 84% B
Dividend Return 9.07% 71% C- 30% F
Total Return 105.24% 85% B 84% B
Average Annual (5 Year Horizon)  
Capital Gain 14.87% N/A N/A 78% C+
Dividend Return 16.24% N/A N/A 76% C+
Total Return 1.37% N/A N/A 32% F
Risk Return Profile  
Volatility (Standard Deviation) 19.85% N/A N/A 52% F
Risk Adjusted Return 81.80% N/A N/A 91% A-
Market Capitalization 0.02B 6% D- 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.